Todos os posts
M-A | Uso de suplementação de ácido fólico para interromper e mesmo reverter a progressão de condições gástricas pré-cancerosas.
12 Ago, 2022 | 17:49hComentário: Can Folic Acid Halt or Reverse Progression of Gastric Precancerous Conditions? – Medscape (necessário cadastro gratuito)
Estudo de coorte | Desfechos neonatais de mães portadoras de alguma deficiência.
12 Ago, 2022 | 17:47hNeonatal Outcomes of Mothers With a Disability – Pediatrics
Comentário: Risk for Complications Increased for Newborns of Moms With Disability – HealthDay
Estudo de coorte | Recorrência de espondiloartrite axial entre parentes de 1º grau em um estudo prospectivo familiar com 35 anos de seguimento.
12 Ago, 2022 | 17:46hComentário: Substantial lifetime risk for axSpA among relatives of patients with ankylosing spondylitis – medwire News
Comentário no Twitter
The frequency of first-degree relatives from HLA B27+ patients with #ankylosingspondylitis to also have was 27.1% in a 35-year follow-up study from 🇨🇭 Mothers with AS were more likely than fathers to pass on the risk to their children. https://t.co/iRGux3lXvm pic.twitter.com/KBzyRZnjQN
— ARD & RMD Open (@ARD_BMJ) July 24, 2022
M-A | Efeitos dos substitutos do sal em desfechos clínicos.
12 Ago, 2022 | 17:44hEffects of salt substitutes on clinical outcomes: a systematic review and meta-analysis – Heart
Comentário: Swapping salt for substitutes reduces risk of stroke and heart conditions – study – The Guardian
Conteúdos relacionados:
RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients
Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths
Comentário da autora no Twitter
Our latest meta-analysis shows consistent effects of salt substitutes on BP across diverse geographies and populations. Protective effects on clinical outcomes are likely to be generalizable to countries worldwide. https://t.co/C273yK6Bek
— Xuejun Yin (@XuejunYin) August 10, 2022
Revisão sistemática | Efeitos da troca de sal por substitutos de sal com baixo sódio na saúde cardiovascular em adultos, crianças e gestantes.
12 Ago, 2022 | 17:42hConteúdos relacionados:
Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis – Heart
RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients
Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths
Estudo randomizado | Em pacientes com estenose intracraniana sintomática, a adição de stent à terapia médica não é melhor a terapia médica isolada para a redução do risco de AVC ou morte.
12 Ago, 2022 | 17:40hEditorial: Therapeutic Strategies for Intracranial Atherosclerosis – JAMA (gratuito por tempo limitado)
Comentário: Stenting Hits Another Wall in Intracranial Stenosis Stroke – MedPage Today (gratuito por tempo limitado)
Comentário no Twitter
Findings of this #RandomizedClinicalTrial do not support the addition of percutaneous transluminal angioplasty and stenting to medical therapy for the treatment of patients with symptomatic severe intracranial atherosclerotic stenosis. https://t.co/X9qi3WQ0JC pic.twitter.com/rH6aDo4GjV
— JAMA (@JAMA_current) August 9, 2022
Estudo randomizado | Em pacientes com AVC oclusivo de grandes vasos, tirofibam intravenoso antes da trombectomia endovascular não melhora os desfechos funcionais.
12 Ago, 2022 | 17:39hEffect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke: The RESCUE BT Randomized Clinical Trial – JAMA (gratuito por tempo limitado)
Ver também: Visual Abstract
Comentário: RESCUE BT: IV Tirofiban No Help During Stroke Thrombectomy – TCTMD
M-A | Associação entre terapia antiplaquetária dupla com ticagrelor e insuficiência de enxerto venoso após cirurgia de revascularização do miocárdio.
12 Ago, 2022 | 17:37hAssociation of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis – JAMA (gratuito por tempo limitado)
Editorial: Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery – JAMA (gratuito por tempo limitado)
Entrevista com o autor: Coronary Artery Bypass Surgery in 2022 – JAMA
Comunicado de imprensa: Two-medication strategy offers both benefit and risk after coronary artery bypass surgery – Weill Cornell Medicine
Estudo de coorte | Mudanças na incidência de AVC e outros eventos vasculares nos jovens vs. em idosos, 2002-2018.
12 Ago, 2022 | 17:33hAssociation of Younger vs Older Ages With Changes in Incidence of Stroke and Other Vascular Events, 2002-2018 – JAMA (gratuito por tempo limitado)
Ver também: Diverging Temporal Trends in Stroke Incidence in Younger vs Older People: A Systematic Review and Meta-analysis – JAMA Neurology (gratuito por tempo limitado)
Comentários no Twitter
Data from Oxford area in @JAMA_current show worrisome incr. in stroke rate in adults <55 yrs comparing two time periods. 67% incr seen in younger adults, 15% decr in older adults. Need further study of why young stroke rates are on the rise#MYStrokeCenterhttps://t.co/MG4MgUGAA4
— Seemant Chaturvedi (@ChaturvediNeuro) August 9, 2022
The consistently divergent temporal trend in stroke incidence at younger vs older ages highlights the urgent need to better understand etiology and prevention of stroke at younger ages. https://t.co/phhRcpWwRw
— JAMA Neurology (@JAMANeuro) August 9, 2022
Ponto de vista | Tornando os registros eletrônicos de saúde melhores e mais seguros.
12 Ago, 2022 | 17:31hMaking Electronic Health Records Both SAFER and SMARTER – JAMA (gratuito por tempo limitado)
Entrevista com os autores: Making Electronic Health Records More Supportive for Clinicians – JAMA
Comentário: Opinion: physicians need to use smarter, safer EHRS – healthleaders
Conteúdos relacionados:
The EMR has changed the doctor-patient duet into a ménage-à-trois – STAT
The future of electronic health records – Nature